| View |
|
DRP-9975-12
|
Cefuroxime (as axetil)
|
Cefulev 500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 March 2024
|
01 July 2026
|
| View |
|
HRP-556
|
Methyl Salicylate
|
None
|
100 g (100%) per 100 mL
|
Solution
|
Counterirritant
|
Dann's Aid Laboratories, Inc.
|
Philippines
|
Renewal
|
29 March 2024
|
18 February 2029
|
| View |
|
HRP-585
|
Eucalyptus Oil
|
None
|
7.5 mL
|
Solution
|
Rubefacient
|
Dann's Aid Laboratories, Inc.
|
Philippines
|
Renewal
|
24 March 2024
|
15 February 2029
|
| View |
|
HRP-585-01
|
Eucalyptus Oil
|
Unbranded
|
7.5 mL
|
Solution
|
Rubefacient
|
Dann’s Aid Laboratories, Inc
|
Philippines
|
Renewal
|
15 March 2024
|
15 February 2029
|
| View |
|
HRP-607
|
Cebo de Macho
|
Unbranded
|
Ointment
|
|
Emollient
|
Dann's Aid Laboratories, Inc.
|
|
Renewal
|
15 March 2024
|
15 February 2029
|
| View |
|
HRP-607-01
|
Cebo de Macho
|
None
|
|
Ointment
|
Emollient
|
Dann’s Aid Laboratories, Inc
|
Philippines
|
Renewal
|
21 March 2024
|
15 February 2029
|
| View |
|
DRP-9166-07
|
Clopidogrel
|
Goplat
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
21 September 2025
|
| View |
|
DRP-9356-02
|
Hyoscine-N-Butylbromide
|
Hyoden
|
20 mg/mL
|
Solution for Injection (I.M./I.V./S.C.)
|
Anticholingeric
|
Farbe Firma
|
India
|
CLIDP Conversion
|
09 February 2023
|
11 December 2025
|
| View |
|
DRP-14284-01
|
Cetirizine Hydrochloride
|
Cetricare-H
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
AKRITI PHARMACEUTICALS PVT. LTD
|
India
|
CLIDP Conversion
|
02 February 2024
|
10 August 2028
|
| View |
|
DRP-8055-05
|
Carvedilol
|
Karved
|
6.25 mg
|
Tablet
|
Combined Alpha and Beta-Adrenoceptor Blocker
|
Akriti Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 January 2024
|
27 March 2027
|
| View |
|
DRP-9637-09
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Avitam 4.5
|
4g/500mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-Lactamase inhibitor)
|
INJECTCARE PARENTERALS PVT. LTD
|
India
|
CLIDP Conversion
|
22 December 2022
|
23 April 2026
|
| View |
|
DRP-9637-08
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Tazasave-4.5
|
4g/500mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
INJECTCARE PARENTERALS PVT. LTD.
|
India
|
CLIDP Conversion
|
12 November 2023
|
24 April 2026
|
| View |
|
DRP-12215-03
|
Acetylcysteine
|
Mufresin
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
07 March 2023
|
01 July 2027
|
| View |
|
DRP-12215-04
|
Acetylcysteine
|
None
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
12 March 2023
|
01 July 2027
|
| View |
|
DRP-12215-05
|
Acetylcysteine
|
Mucocystein
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
Automatic Renewal (Variation)
|
20 July 2023
|
01 July 2027
|
| View |
|
DRP-15100
|
Paclitaxel
|
Claxel
|
6 mg/mL (30 mg/5 mL, 100 mg/16.7 mL and 300 mg/50 mL)
|
Concentrate for Solution for I.V. Infusion
|
Antineoplastic Agent
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
Initial
|
18 June 2021
|
18 June 2026
|
| View |
|
DRMO-101
|
Medical Grade Oxygen
|
None
|
None
|
None
|
Medical Gas
|
Pryce Gases, Inc.
|
Philippines
|
Initial Rx
|
17 April 2024
|
17 April 2029
|
| View |
|
DR-XY49056
|
Gliclazide
|
Glynoprex MR
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
The ACME Laboratories Limited
|
Bangladesh
|
Initial
|
18 April 2024
|
18 April 2029
|
| View |
|
DRP-15078
|
Sitagliptin (as hydrochloride) + Metformin
Hydrochloride
|
Sitazit-M
|
50 mg/850 mg
|
Film-Coated Tablet
|
Antidiabetic
|
Hetero Labs Limited (Unit V)
|
India
|
Initial
|
17 April 2024
|
17 April 2029
|
| View |
|
DRP-15089
|
Ganciclovir
|
None
|
250 mg
|
Lyophilized Powder for IV Injection
|
Antiviral (Nucleoside and nucleotide excl. reverse transcriptase inhibitor)
|
Hainan Brillant Pharmaceutical Co., Ltd.
|
China
|
Initial
|
18 April 2024
|
18 April 2029
|